Clinicopathological significance of ERCC1 expression in breast cancer
Authors:
- Ana CarvalhoACAna Carvalho
- Vítor CarneiroVCVítor Carneiro
- Rui San BentoRBRui San Bento
- Gilberto UemuraGUGilberto Uemura
- Madalena GomesMGMadalena Gomes
- André AlbergariaAAAndré Albergaria
- Fernando SchmittFernando Schmitt
- 1 June 2013
- journal article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 209 (6) , 331-336
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Measuring β‐tubulin III, Bcl‐2, and ERCC1 improves pathological complete remission predictive accuracy in breast cancerCancer Science, 2011
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011Annals of Oncology, 2011
- Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologistsLaboratory Investigation, 2011
- Clinicopathologic Significance of Excision Repair Cross-Complementation 1 Expression in Patients Treated With Breast-Conserving Surgery and Radiation TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapyBreast Cancer Research and Treatment, 2008
- Tissue microarrays for testing basal biomarkers in familial breast cancer casesSao Paulo Medical Journal, 2007
- Excision Repair Cross Complementation Group 1 Immunohistochemical Expression Predicts Objective Response and Cancer-Specific Survival in Patients Treated by Cisplatin-Based Induction Chemotherapy for Locally Advanced Head and Neck Squamous Cell CarcinomaClinical Cancer Research, 2007
- Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapyAnnals of Oncology, 2007
- ERCC1 expression as a molecular marker of cisplatin resistance in human cervical tumor cellsInternational Journal of Cancer, 2000
- Psoriasin (S100A7) Expression and Invasive Breast CancerThe American Journal of Pathology, 1999